News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,161 Results
Type
Article (30276)
Company Profile (239)
Press Release (372639)
Multimedia
Podcasts (130)
Webinars (14)
Section
Business (116281)
Career Advice (928)
Deals (17778)
Drug Delivery (97)
Drug Development (64399)
Employer Resources (77)
FDA (9657)
Job Trends (7960)
News (194734)
Policy (20420)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (1788)
Accelerated approval (48)
ADA (37)
Adcomms (32)
Allergies (172)
Alliances (27886)
ALS (204)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (505)
Approvals (10070)
Artificial intelligence (505)
ASCO (256)
Autoimmune disease (343)
Automation (26)
Bankruptcy (162)
Best Places to Work (6848)
BIO (59)
Biologics (2)
BIOSECURE Act (12)
Biosimilars (196)
BioSpace Insights (84)
Biotechnology (187)
Bladder cancer (164)
Brain cancer (74)
Breast cancer (565)
Cancer (5140)
Cardiovascular disease (417)
Career advice (797)
Career pathing (28)
CAR-T (328)
CDC (51)
Celiac Disease (1)
Cell therapy (865)
Cervical cancer (40)
Clinical research (56458)
Collaboration (1796)
Commercialization (5)
Company closure (4)
Compensation (981)
Complete response letters (82)
COVID-19 (2512)
CRISPR (121)
C-suite (975)
Cystic fibrosis (153)
Data (7570)
Decentralized trials (2)
Denatured (25)
Depression (146)
Dermatology (100)
Diabetes (507)
Diagnostics (2936)
Digital health (30)
Diversity (9)
Diversity, equity & inclusion (30)
Drug discovery (348)
Drug pricing (139)
Drug shortages (18)
Duchenne muscular dystrophy (335)
Earnings (43094)
Editorial (55)
Employer branding (9)
Employer resources (79)
Events (65809)
Executive appointments (823)
FDA (12850)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1524)
Gene editing (251)
Generative AI (49)
Gene therapy (730)
GLP-1 (846)
Government (3145)
Grass and pollen (6)
Guidances (282)
Healthcare (10618)
Hematology (151)
HIV (67)
Huntington's disease (66)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (301)
Immuno-oncology (97)
Indications (194)
Infectious disease (2863)
Inflammatory bowel disease (201)
Inflation Reduction Act (13)
Influenza (129)
Intellectual property (257)
Interviews (167)
IPO (9188)
IRA (40)
Job creations (1402)
Job search strategy (662)
JPM (52)
Kidney cancer (19)
Labor market (52)
Layoffs (362)
Leadership (25)
Legal (5754)
Licensing (10)
Liver cancer (64)
Longevity (38)
Lung cancer (680)
Lymphoma (397)
Machine learning (44)
Management (23)
Manufacturing (740)
Marketing (13)
MASH (183)
Medical affairs (1)
Medical device (4852)
Medtech (4928)
Mergers & acquisitions (9533)
Metabolic disorders (1353)
mRNA (247)
Multiple sclerosis (170)
NASH (16)
Neurodegenerative disease (432)
Neuropsychiatric disorders (108)
Neuroscience (3157)
Neurotech (1)
NextGen: Class of 2026 (3297)
Non-profit (2367)
Now hiring (43)
Obesity (620)
Opinion (239)
Ovarian cancer (214)
Pain (183)
Pancreatic cancer (289)
Parkinson's disease (364)
Partnered (20)
Patents (520)
Patient recruitment (711)
Peanut (64)
People (33137)
Pharmaceutical (32)
Pharmacy benefit managers (17)
Phase 1 (18608)
Phase 2 (25229)
Phase 3 (18020)
Pipeline (8787)
Policy (234)
Postmarket research (1661)
Preclinical (8067)
Press Release (38)
Prostate cancer (269)
Psychedelics (77)
Radiopharmaceuticals (323)
Rare diseases (1185)
Real estate (2090)
Recruiting (32)
Regulatory (16298)
Reports (36)
Research institute (1640)
Resumes & cover letters (148)
Rett syndrome (50)
RNA editing (31)
RSV (96)
Schizophrenia (171)
Series A (282)
Series B (198)
Service/supplier (2)
Sickle cell disease (123)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (26)
Startups (2348)
State (1)
Stomach cancer (12)
Supply chain (70)
Tariffs (49)
The Weekly (103)
Vaccines (1175)
Venture capital (111)
Weight loss (384)
Women's health (86)
Worklife (12)
Date
Last 7 days (274)
Last 30 days (1651)
Last 365 days (21690)
2026 (14067)
2025 (21911)
2024 (24813)
2023 (27458)
2022 (35017)
2021 (37248)
2020 (32752)
2019 (24787)
2018 (18270)
2017 (18577)
2016 (17296)
2015 (20349)
2014 (14893)
2013 (11239)
2012 (11437)
2011 (11838)
2010 (11120)
Location
Africa (412)
Alabama (83)
Alaska (3)
Arizona (152)
Arkansas (8)
Asia (24919)
Australia (4581)
California (10583)
Canada (2799)
China (1311)
Colorado (386)
Connecticut (435)
Delaware (373)
Europe (60122)
Florida (1479)
Georgia (347)
Hawaii (5)
Idaho (26)
Illinois (720)
India (82)
Indiana (435)
Iowa (13)
Japan (468)
Kansas (96)
Kentucky (26)
Louisiana (31)
Maine (40)
Maryland (1214)
Massachusetts (8276)
Michigan (170)
Minnesota (416)
Mississippi (3)
Missouri (86)
Montana (19)
Nebraska (8)
Nevada (81)
New Hampshire (35)
New Jersey (2742)
New Mexico (17)
New York (2708)
North Carolina (1226)
North Dakota (7)
Northern California (5398)
Ohio (271)
Oklahoma (13)
Oregon (28)
Pennsylvania (2072)
Puerto Rico (14)
Rhode Island (32)
South America (488)
South Carolina (22)
South Dakota (1)
Southern California (4247)
Tennessee (106)
Texas (1496)
United States (36260)
Utah (195)
Vermont (1)
Virginia (210)
Washington D.C. (48)
Washington State (859)
West Virginia (1)
Wisconsin (89)
403,161 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MustGrow Receives First Milestone Payment from Bayer AG
• Bayer AG has paid MustGrow the first development milestone payment. • The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s mustard-based biocontrol technologies in Europe, Middle East and Africa.
August 21, 2026
·
6 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
July 1, 2026
·
13 min read
Press Releases
Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen’s Rare Disease pipeline
July 22, 2026
·
7 min read
Press Releases
DeepoMe Introduces the First Biomedical World Model for Chronic Disease Management and Aging Intervention
New preprint by Jianghui Xiong, PhD, and the DeepoMe team introduces SteeraMed, a steerable biomedical world model for N-of-1 intervention reasoning across chronic diseases and aging
May 26, 2026
·
1 min read
Funding
Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases
George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.
April 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting
May 27, 2026
·
3 min read
Press Releases
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
June 18, 2026
·
4 min read
Press Releases
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
August 11, 2026
·
3 min read
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
1 of 40,317
Next
